Anne Glover, co-founder with Cambridge's Hermann Hauser of Amadeus Capital Partners, has been formally recognised for her outstanding contributions to science, engineering, and innovation in the UK and been awarded a Damehood.

Unlock five decades of artificial-intelligence evolution insight in one conversation.

Healthcare Venture Capitalist Vishal Gulati Inducted Into The Academy Of Medical Sciences In Recognition Of His Role In Translational Medicine.

A two-day Ventures Tour featuring a range of portfolio pitch sessions hosted by some of Cambridge’s most prominent venture capital firms, venture builders, incubators, accelerators and business angels, has been introduced to the Cambridge Wide Open Week life science showcase in June.

A longstanding member of Cambridge Angels, James studied engineering at Trinity College, Cambridge before spending his career in investment banking in London & New York. Now an angel investor and non-executive director with his professional advisory days behind him, he is one of our resident experts on exits and exit planning.

Innovate Cambridge has assembled a group of world-class tech and science leaders to steer a novel innovation and growth blueprint the length and breadth of the planet.

Cambridge University is famed worldwide for the entrepreneurship of its academics and for the spin-outs from their brilliant research. There is just one problem – women are vastly underrepresented, writes Dorothy Byrne, President of Murray Edwards College, University of Cambridge. Only four per cent of teams in Cambridge spin-outs are all female while 67 per cent are all male.

We are delighted to share that on Tuesday 4th March at the 2025 UKIE (The Association for UK Interactive Entertainment) awards, Frontier President and Founder David Braben was inducted into the UK Games Industry Hall of Fame.

Cambridge Innovation Capital has launched a new £100 million Opportunity Fund – anchored by Aviva Investors and British Patient Capital – to invest in growing DeepTech and life science companies.

In February 2023, the BVCA brought out their latest set of Series A model investment documents (‘the Model Documents”).